Clinical Trial Update: CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/3 study evaluating preoperative Cisplatin, Gemcitabine, and Nab-paclitaxel (GAP) versus immediate resection in resectable bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2, Phase 3 | Status: RECRUITING